Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder

NCT04421248 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

214

Enrollment

OTHER

Sponsor class

Conditions

Attention Deficit Hyperactivity Disorder Combined

Interventions

DRUG: Methylphenidate
DRUG: Placebo

Sponsor

Donald Gilbert, MD, MS, FAAN, FAAP

Collaborators

[object Object]